Federal Register / Vol. 73, No. 189 / Monday, September 29, 2008 / Notices 56611 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Cooperative Research 

Group on Development and Evaluation 

of a Gas Chromatograph Testing 

Protocol 

Notice is hereby given that, on August 

26, 2008, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Southwest Research 

Institute—Cooperative Research Group 

on Development and Evaluation of a Gas 

Chromatograph Testing Protocol 

(‘‘GCTP’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, EffeTech, Ltd., 

Staffordshire, UNITED KINGDOM has 

been added as a party to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and GCTP intends 

to file additional written notifications 

disclosing all changes in membership. 

On March 6, 2008, GCTP filed its 

original notification pursuant to 

Section6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to Section 

6(b) of the Act on April 7, 2008 (73 FR 

18813). 

The last notification was filed with 

the Department on June 4, 2008. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on July 16, 2008 (73 FR 40882). 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. E8–22663 Filed 9–26–08; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—IMS Global Learning 

Consortium, Inc. 

Notice is hereby given that, on August 

28, 2008, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’)/IMS Global Learning 

Consortium, Inc. has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, CREDU Co., Ltd., Seoul, 

REPUBLIC OF KOREA; DaulSoft Co., 

Ltd., Seoul, REPUBLIC OF KOREA; 

Laureate Online Education, Baltimore, 

MD; Miami-Dade College—Virtual 

College, Miami, FL; and Utah Valley 

University, Orem, UT have been added 

as parties to this venture. Also, 

Intrallect, Scotland, UNITED KINGDOM 

has withdrawn as a party to this 

venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and IMS Global 

Learning Consortium, Inc. intends to file 

additional written notifications 

disclosing all changes in membership. 

On April 7, 2000, IMS Global 

Learning Consortium, Inc. filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on September 13, 2000 (65 FR 

55283). 

The last notification was filed with 

the Department on June 10, 2008. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on July 21, 2008 (73 FR 42367). 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. E8–22662 Filed 9–26–08; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Digital Entertainment 

Content Ecosystem (DECE) LLC 

Notice is hereby given that, on August 

25, 2008, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Digital 

Entertainment Content Ecosystem 

(DECE) LLC (‘‘DECE’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to Section 6(b) of the Act, 

the name and principal place of 

business of the standards development 

organization is: Digital Entertainment 

Content Ecosystem (DECE) LLC, Culver 

City, CA. The nature and scope of 

DECE’s standards development 

activities are: (1) To enable the delivery 

of digital entertainment content in a 

manner that allows for interoperability 

among digital formats and digital rights 

management systems; and (2) to develop 

specifications accordingly. 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. E8–22661 Filed 9–26–08; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule II, and prior to 

issuing a regulation under 21 U.S.C. 

952(a)(2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with Title 21 

Code of Federal Regulations (CFR), 

1301.34(a), this is notice that on August 

18, 2008, GE Healthcare, 3350 North 

Ridge Avenue, Arlington Heights, 

Illinois 60004–1412, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of Cocaine (9041), a basic 

class of controlled substance listed in 

schedule II. 

The company plans to import small 

quantities of ioflupane, in the form of 

three separate analogues of Cocaine, to 

validate production and QC systems; for 

a reference standard; and for producing 

material for future investigational new 

drug (IND) submission. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

mstockstill on PROD1PC66 with NOTICES